SEED.L $1.94 -0.641%
XSDR.L $18 174.38 0.7337%
0LRK.L $195.64 0.2562%
0QNU.L $73.80 -2.122%
0HST.L $54.46 0.1648%
IVAN $7.68 0%
HSC $9.10 -1.4626%
QSWN $18.27 1.1079%
RHP $94.78 -0.5769%
GIIXU $10.06 0%
CTMX $1.82 2.5424%
BTCS $1.33 -3.529%
JMAC $10.81 0%
2017.HK $0.24 0%
NCBS $75.35 0%
GST.L $1.45 5.4545%
FLLV $46.82 -0.4677%
SWSSU $10.59 0%
EARS $3.05 0%
ANTE $1.19 -8.4615%
ALPN $8.00 2.8278%
TSAT $8.75 1.8626%
SHAK $65.23 -1.9702%
SWBK $9.35 0%
2299.HK $4.25 0%
0780.HK $15.36 0.6553%
3988.HK $3.21 -1.8349%
GCVB.L $42.06 -0.2372%
TREX $56.29 -3.0986%
0QZS.L $15.52 -2.6553%
ADXN $0.90 1.2261%
ZY $2.43 0%
ARBG $10.15 0%
WTREP $25.09 0%
FCO $5.06 0%
BSTP $25.55 -0.409%
0RGI.L $52.00 -1.3581%
SNSE $1.48 -0.6711%
CPI $25.01 -0.2246%
HJLI $10.38 0%
1793.HK $0.17 0%
1626.HK $3.21 0%
CMS-PC $18.63 0.6391%
COMB $20.50 0.0351%
IDHC.L $0.47 1.7391%
RGA $147.75 -1.1673%
SQNS $2.33 1.3043%
0KXO.L $104.18 3.147%
2362.HK $0.51 -5.5556%
2083.HK $1.69 0%
MGMT $32.45 0.0749%
0770.HK $0.18 -8.80829%
ADBE $332.41 -2.6846%
FNGO $26.23 -2.7438%
HOLI $15.22 -1.9961%
0SE5.L $95.04 -0.8872%
STBX $3.44 -1.7143%
RPV $71.06 -1.072%
XMVM $40.90 -0.523%
FJV.L $176.50 1.7291%
XUFB.L $1 320.00 -0.7444%
SGBP.L $58.22 0.3966%
0G68.L $18.60 1.2162%
IWFL $21.17 -0.2953%
VOOG $232.61 -0.6535%
0897.HK $0.39 -3.75%
0068.HK $0.52 0%
TIPZ $55.09 -0.0907%
0HJR.L $171.89 0.1865%
ARTEW $0.05 -19.7432%
OAS $109.30 0%
CCL $9.71 -5.1758%
XMVU.L $46.15 -0.1946%
PAY $9.11 -0.9783%
QQQ3.L $85.41 -1.2716%
IPXE.L $13.93 -21.3435%
UKEL.L $5.02 0.0797%
ALFIW $0.22 0%
ANZUU $10.15 0.2964%
0592.HK $0.32 0%
IMB.L $1 885.00 0.186%
3833.HK $1.30 -2.9851%
0030.HK $0.25 0%
PUBM $15.17 0.2644%
QULL $23.99 0%
FDEU $13.06 -0.0383%
0KZA.L $26.19 2.2324%
6185.HK $32.60 -3.5503%
RCLFW $0.15 0%
HALL $4.15 10.2819%
UJB $61.78 -0.206%
BRSP $5.34 -0.8364%
MCW $9.16 -1.6112%
DRI $147.67 0.449%
ITRN $21.10 -0.939%
ALOBR.PA $8.20 -1.2048%
FOXA $30.50 -0.5543%
CONXU $10.30 0.2921%
GH $26.59 -1.9181%
Eng
Логотип
Eng
Лого

Arecor Therapeutics plc AREC.L

$255.00

На 18:04, 12 мая 2023

Ключевые показатели

  • Marketcap

    79607320.00000000

  • week52high

    400.00

  • week52low

    200.00

  • Revenue

    2403000

  • P/E TTM

    0

  • Beta

    0.00000000

  • EPS

    -0.33000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    20 апр 2023 г. в 10:00

Описание компании

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек